Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System for Tricuspid Regurgitation

NCT05486832 is registered in ClinicalTrials.gov with Cardiovalve Ltd. as lead sponsor.

NCT NCT05486832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05486832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System for Tricuspid Regurgitation
Lead sponsor
Cardiovalve Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 9, 2022
Completion date
December 15, 2031
Enrollment
157 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation